ID   B2M-/- Elf1
AC   CVCL_YY07
DR   WiCell; b2m-elf1
DR   Wikidata; Q98125532
RX   PubMed=28504668;
CC   Knockout cell: Method=Recombinant Adeno-Associated Virus; HGNC; 914; B2M.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=b2m-elf1
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 11
ST   D18S51: 15,18
ST   D21S11: 29,31
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 24
ST   Penta D: 13,14
ST   Penta E: 5,12
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C115 ! Elf1
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 5
//
RX   PubMed=28504668; DOI=10.1038/nbt.3860;
RA   Gornalusse G.G., Hirata R.K., Funk S.E., Riolobos L., Lopes V.S.,
RA   Manske G., Prunkard D., Colunga A.G., Hanafi L.-A., Clegg D.O.,
RA   Turtle C., Russell D.W.;
RT   "HLA-E-expressing pluripotent stem cells escape allogeneic responses
RT   and lysis by NK cells.";
RL   Nat. Biotechnol. 35:765-772(2017).
//